首页> 外文OA文献 >PIN67 Cost-Effectiveness of Peginterferon Alfa and Ribavirin for the Treatment of Children and Young People with Chronic Hepatitis C from the Perspective of the NHS in England and Wales

【2h】

PIN67 Cost-Effectiveness of Peginterferon Alfa and Ribavirin for the Treatment of Children and Young People with Chronic Hepatitis C from the Perspective of the NHS in England and Wales

机译：从英格兰和威尔士的NHS角度看，PIN67干扰素阿尔法和利巴韦林治疗慢性丙型肝炎的儿童和年轻人的成本效益

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Lion M.; McCann E.; Jiang Y.;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The clinical effectiveness and cost-effectiveness of peginterferon alfa and ribavirin for the treatment of chronic hepatitis C in children and young people: a systematic review and economic evaluation [J] . Health technology assessment: HTA . 2014,第65期

机译：聚乙二醇干扰素α和利巴韦林治疗儿童和年轻人慢性丙型肝炎的临床疗效和成本效益：系统评价和经济评价
2. Cost-effectiveness analysis of treatment with peginterferon-alfa-2a versus peginterferon-alfa-2b for patients with chronic hepatitis C under the public payer perspective in Brazil [J] . Fabio MR Barros, Hugo Cheinquer, Carolina T Tsuchiya, Cost Effectiveness and Resource Allocation . 2013,第1期

机译：在巴西公共付款人的角度下，peginterferon-alfa-2a与peginterferon-alfa-2b治疗慢性丙型肝炎的成本效益分析
3. Cost-effectiveness analysis of treatment with peginterferon-alfa-2a versus peginterferon-alfa-2b for patients with chronic hepatitis C under the public payer perspective in Brazil [J] . Fabio MR Barros, Hugo Cheinquer, Carolina T Tsuchiya, Cost Effectiveness Resource Allocation . 2013,第2期

机译：在巴西公共付款人的角度下，peginterferon-alfa-2a与peginterferon-alfa-2b治疗慢性丙型肝炎的成本效益分析
4. Patients with HCV/HIV Co-infection Achieving a Sustained Virological Response Following HCV Treatment with Peginterferon alfa-2a (PEGASYS) plus Ribavirin (COPEGUS) have Improved Health Related Quality of Life [C] . D.T. Dieterich, M. Rodriguez Torres, J.K. Rockstroh International AIDS Conference . 2004

机译：HCV / HIV的患者在用Peginterferon Alfa-2a（Pegasys）加上利巴韦林（Copegegs）后HCV治疗后实现持续的病毒学反应，具有改善的健康相关的生活质量
5. The meaning of adherence among veterans receiving pegylated interferon and ribavirin antiviral treatment for chronic hepatitis C. [D] . Phillips, Frances Hinshaw. 2011

机译：接受聚乙二醇干扰素和利巴韦林抗病毒治疗的慢性丙型肝炎退伍军人依从性的含义。
6. The clinical effectiveness and cost-effectiveness of peginterferon alfa and ribavirin for the treatment of chronic hepatitis C in children and young people: a systematic review and economic evaluation. [O] . Debbie Hartwell, Keith Cooper, Geoff K Frampton, -1

机译：聚乙二醇干扰素α和利巴韦林在儿童和年轻人中治疗慢性丙型肝炎的临床疗效和成本效益：系统评价和经济评价。
7. PIN8 COST-EFFECTIVENESS ANALYSIS OF PEGINTERFERON (ALFA-2B) WITH RIBAVIRIN COMPARED WITH PEGINTERFERON (ALFA-2A) WITH RIBAVIRIN FOR THE TREATMENT OF CHRONIC HEPATITIS C [O] . Omelyanovsky VV, Avksentieva MV, Krysanov I, 2010

机译：利巴韦林与PEG干扰素（ALFA-2A）联合利巴韦林的PIN8成本效益分析治疗慢性丙型肝炎C

PIN67 Cost-Effectiveness of Peginterferon Alfa and Ribavirin for the Treatment of Children and Young People with Chronic Hepatitis C from the Perspective of the NHS in England and Wales

著录项

引文网络

相似文献

相关主题

期刊订阅